Clinical trial
A Randomized Study of Post-Remission Therapy in Elderly Patients With Acute…
NCT00363025 · Acute Leukemia French Association, Other · Terminated
Key facts
| NCT number | NCT00363025 |
|---|---|
| Title | A Randomized Study of Post-Remission Therapy in Elderly Patients With Acute Myelogenous Leukemia. |
| Official title | A Randomized Multicenter Study of More Intensive Versus Less Intensive Post-Remission Therapy in Elderly Patients With Acute Myelogenous Leukemia (AML) or Transformed Refractory Anemia With Excess Blasts (RAEB-t). |
| Lead sponsor | Acute Leukemia French Association, Other |
| Collaborators | Assistance Publique - Hôpitaux de Paris |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Acute Myeloid Leukemia |
| Intervention type | Drug, Procedure |
| Interventions | Two post-remission strategies, Idarubicin versus daunorubicin |
| Enrollment | 465 |
| Start date | Nov 1, 1999 |
| Completion | Apr 1, 2006 |
| First posted | Aug 15, 2006 |
| Last update posted | Feb 21, 2008 |
| Countries | France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: